X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5065) 5065
Publication (646) 646
Book Review (78) 78
Book Chapter (28) 28
Newspaper Article (20) 20
Newsletter (18) 18
Conference Proceeding (16) 16
Dissertation (7) 7
Book / eBook (3) 3
Data Set (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3787) 3787
index medicus (2849) 2849
animals (2328) 2328
apoptosis (1729) 1729
mice (1263) 1263
female (1156) 1156
oncology (1078) 1078
male (1056) 1056
cell biology (969) 969
cell line, tumor (926) 926
cancer (919) 919
tumor-necrosis-factor (868) 868
expression (856) 856
nf-kappa-b (827) 827
inflammation (797) 797
signal transduction (788) 788
biochemistry & molecular biology (775) 775
apoptosis - drug effects (734) 734
immunology (718) 718
cytokines (709) 709
proteins (697) 697
tumors (648) 648
gene expression (611) 611
research (611) 611
tumor necrosis factor-alpha - metabolism (606) 606
trail (595) 595
osteoprotegerin (590) 590
tumor necrosis factor (590) 590
activation (549) 549
ligands (520) 520
tumor necrosis factor-tnf (508) 508
cells, cultured (490) 490
middle aged (469) 469
health aspects (453) 453
receptors, tumor necrosis factor - metabolism (435) 435
tnf-related apoptosis-inducing ligand (432) 432
adult (423) 423
cells (422) 422
research article (415) 415
analysis (405) 405
physiological aspects (405) 405
medicine, research & experimental (396) 396
in-vivo (390) 390
article (377) 377
medicine (367) 367
kinases (364) 364
multidisciplinary sciences (361) 361
nf-kappa b - metabolism (353) 353
membrane glycoproteins - metabolism (349) 349
aged (346) 346
tumor necrosis factor-alpha - pharmacology (346) 346
care and treatment (340) 340
apoptosis regulatory proteins (339) 339
up-regulation (330) 330
antineoplastic agents - pharmacology (328) 328
death (328) 328
metastasis (323) 323
endocrinology & metabolism (322) 322
review (322) 322
genetic aspects (318) 318
apoptosis - physiology (314) 314
caspases - metabolism (314) 314
tnf-related apoptosis-inducing ligand - pharmacology (313) 313
tnf-related apoptosis-inducing ligand - metabolism (312) 312
biology (306) 306
gene-expression (303) 303
rats (303) 303
in-vitro (301) 301
signal transduction - drug effects (298) 298
receptors, tnf-related apoptosis-inducing ligand - metabolism (297) 297
tnf-alpha (297) 297
ligand (295) 295
receptor (294) 294
mice, inbred c57bl (293) 293
rodents (293) 293
rank ligand (291) 291
development and progression (285) 285
cell line (280) 280
disease models, animal (277) 277
flow cytometry (275) 275
tumor cells, cultured (273) 273
down-regulation (270) 270
blotting, western (269) 269
immunohistochemistry (268) 268
rna, messenger - metabolism (268) 268
apoptosis-inducing ligand (267) 267
reverse transcriptase polymerase chain reaction (265) 265
receptors, tumor necrosis factor (264) 264
science (259) 259
medicine & public health (255) 255
inhibition (254) 254
cell proliferation (250) 250
receptor activator (244) 244
receptor activator of nuclear factor-kappa b (243) 243
cell death (240) 240
rheumatoid-arthritis (239) 239
trail-induced apoptosis (239) 239
cytokines - metabolism (238) 238
pathology (238) 238
pharmacology & pharmacy (235) 235
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5111) 5111
Japanese (16) 16
Chinese (11) 11
Polish (3) 3
Russian (2) 2
Spanish (2) 2
Corsican (1) 1
Dutch (1) 1
Italian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Molecular and Cellular Biology, ISSN 0270-7306, 10/2006, Volume 26, Issue 19, pp. 7046 - 7055
Article Usage Stats Services MCB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley... 
CANCER-CELLS | APO2L/TRAIL | DEATH RECEPTORS | ACTIVATION | PROTEIN | INDUCED APOPTOSIS | BIOCHEMISTRY & MOLECULAR BIOLOGY | RESISTANCE | CASPASE-8 | NF-KAPPA-B | EXPRESSION | CELL BIOLOGY | Receptors, Tumor Necrosis Factor - metabolism | Apoptosis Regulatory Proteins - pharmacology | Apoptosis - drug effects | Jurkat Cells | Humans | Membrane Glycoproteins - pharmacology | Cells, Cultured | GPI-Linked Proteins | Enzyme Activation - drug effects | Receptors, TNF-Related Apoptosis-Inducing Ligand | Death Domain Receptor Signaling Adaptor Proteins | Receptors, Tumor Necrosis Factor, Member 10c | Tumor Necrosis Factor Receptor-Associated Peptides and Proteins - metabolism | Tumor Necrosis Factor Decoy Receptors | Tumor Necrosis Factor-alpha - pharmacology | Caspases - metabolism | Membrane Glycoproteins - antagonists & inhibitors | TNF-Related Apoptosis-Inducing Ligand | Membrane Microdomains - drug effects | Protein Binding - drug effects | Apoptosis Regulatory Proteins - antagonists & inhibitors | HeLa Cells | Tumor Necrosis Factor-alpha - antagonists & inhibitors | Membrane Microdomains | Tumor Necrosis Factor Receptor-Associated Peptides and Proteins | Biochemistry, Molecular Biology | Tumor Necrosis Factor-alpha | Life Sciences | Apoptosis Regulatory Proteins | Receptors, Tumor Necrosis Factor | Protein Binding | Caspases | Enzyme Activation | Membrane Glycoproteins | Hela Cells | Apoptosis
Journal Article
Structure, ISSN 0969-2126, 2011, Volume 19, Issue 2, pp. 162 - 171
Decoy Receptor 3 (DcR3), a secreted member of the Tumor Necrosis Factor (TNF) receptor superfamily, neutralizes three different TNF ligands: FasL, LIGHT, and... 
NECROSIS-FACTOR RECEPTOR | CRYSTAL-STRUCTURE | BIOCHEMISTRY & MOLECULAR BIOLOGY | TUMOR | TNF SUPERFAMILY | T-CELL | FACTOR-ALPHA | TL1A | CELL BIOLOGY | BIOPHYSICS | LIGHT-MEDIATED APOPTOSIS | FACTOR SUPERFAMILY | LIGAND | Fas Ligand Protein - metabolism | Receptors, Tumor Necrosis Factor, Member 6b - metabolism | Humans | Molecular Conformation | Molecular Sequence Data | Crystallography, X-Ray | Fas Ligand Protein - immunology | Signal Transduction - immunology | Receptors, Tumor Necrosis Factor, Member 6b - immunology | Cloning, Molecular | Receptors, Tumor Necrosis Factor, Member 6b - genetics | Tumor Necrosis Factor Ligand Superfamily Member 15 - genetics | Protein Structure, Tertiary | Recombinant Proteins - metabolism | Amino Acid Sequence | Mutagenesis, Site-Directed | Tumor Necrosis Factor Ligand Superfamily Member 14 - immunology | Cells, Cultured | Crystallization | Recombinant Proteins - genetics | Tumor Necrosis Factor Ligand Superfamily Member 15 - metabolism | Tumor Necrosis Factor Ligand Superfamily Member 14 - metabolism | Tumor Necrosis Factor Ligand Superfamily Member 15 - immunology | Animals | Drosophila melanogaster | Index Medicus | Decoys | Stoichiometry | Receptors | Ligands | Strategy | Biochemistry | Invariants | Crystal structure | ATOMS | CRYSTAL STRUCTURE | MUTAGENESIS | MATERIALS SCIENCE | SPECIFICITY | AFFINITY
Journal Article
Journal Article
Journal of Cerebral Blood Flow & Metabolism, ISSN 0271-678X, 10/2012, Volume 32, Issue 10, pp. 1933 - 1938
Tumor necrosis factor (TNF)-α is produced in brain in response to acute cerebral ischemia, and promotes neuronal apoptosis. Biologic TNF inhibitors (TNFIs),... 
blood-brain barrier | TNFa inhibitors | monoclonal antibody | stroke | PRIMATE | FOCAL CEREBRAL-ISCHEMIA | MOUSE | INJURY | NECROSIS-FACTOR-ALPHA | MONOCLONAL-ANTIBODY | NEUROSCIENCES | NEUROPROTECTION | TNF alpha inhibitors | ENDOCRINOLOGY & METABOLISM | HEMATOLOGY | NF-KAPPA-B | EXPRESSION | BINDING | Neuroprotective Agents - therapeutic use | Recombinant Fusion Proteins - immunology | Infarction, Middle Cerebral Artery - prevention & control | Neuroprotective Agents - immunology | Humans | Recombinant Fusion Proteins - therapeutic use | Antibodies, Monoclonal - therapeutic use | Receptors, Tumor Necrosis Factor - therapeutic use | Stroke - pathology | Neuroprotective Agents - administration & dosage | Antibodies, Monoclonal - immunology | Recombinant Fusion Proteins - administration & dosage | CHO Cells | Cricetinae | Stroke - prevention & control | Receptors, Tumor Necrosis Factor - administration & dosage | Infarction, Middle Cerebral Artery - pathology | Brain - drug effects | Immunoglobulin gamma-Chains - therapeutic use | Administration, Intravenous | Animals | Immunoglobulin gamma-Chains - immunology | Antibodies, Monoclonal - administration & dosage | Receptors, Transferrin - immunology | Brain - pathology | Mice | Receptors, Tumor Necrosis Factor - immunology | Tumor Necrosis Factor-alpha - antagonists & inhibitors | Immunoglobulin gamma-Chains - administration & dosage | Drugs | Tumor necrosis factor receptors | Brain | Neuroprotection | Stroke | Intravenous administration | etanercept | Blood-brain barrier | Ischemia | Cerebral blood flow | Tumor necrosis factor | Monoclonal antibodies | Genetic engineering | Fusion protein | Transferrin receptors | Tumor necrosis factor- alpha | Apoptosis | blood–brain barrier | TNFα inhibitors, monoclonal antibody | Original
Journal Article
Journal Article
Science, ISSN 0036-8075, 8/1997, Volume 277, Issue 5327, pp. 818 - 821
Journal Article
Journal Article
Journal Article